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Keratin intermediate filaments are important cy-
toskeletal structural proteins involved in maintaining
cell shape and function. Mutations in the epidermal ker-
atin genes, keratin 5 or keratin 14 lead to the disruption
of keratin filament assembly, resulting in an autosomal
dominant inherited blistering skin disease, epidermoly-
sis bullosa simplex (EBS). We investigated a large EBS
kindred who exhibited a markedly heterogeneous clin-
ical presentation and detected two distinct keratin 5
mutations in the proband, the most severely affected.
One missense mutation (E170K) in the highly conserved
helix initiation peptide sequence of the 1A rod domain
was found in all the affected family members. In con-
trast, the other missense mutation (E418K) was found
only in the proband. The E418K mutation was located in
the stutter region, an interruption in the heptad repeat
regularity, whose function as yet remains unclear. We
hypothesized that this mutated stutter allele was clini-
cally silent when combined with the wild type allele but
aggravates the clinical severity of EBS caused by the
E170K mutation on the other allele. To confirm this in
vitro, we transfected mutant keratin 5 cDNA into cul-
tured cells. Although only 12.7% of the cells transfected
with the E170K mutation alone showed disrupted kera-
tin filament aggregations, significantly more cells
(30.0%) cotransfected with both E170K and E418K muta-
tions demonstrated keratin aggregation (p < 0.05).
These transfection assay results corresponded to the
heterogeneous clinical findings of the EBS patient in
this kindred. We have identified the first case of both
compound heterozygous dominant (E170K) and reces-
sive (E418K) mutations in any keratin gene and con-
firmed the significant involvement of the stutter region
in the assembly and organization of the keratin inter-
mediate filament network in vitro.
The epidermis plays an important role in the protection from
environmental insult by forming an extensive cytoskeletal net-
work within keratinocytes, comprising of keratin intermediate
filaments (KIF)1 belonging to the intermediate filaments (IF)
superfamily (1, 2). Keratins can be subdivided into two sepa-
rate subfamilies, type I, the acidic keratins, and type II, the
neutral-basic keratins (3–5). They have a central 310-amino
acid -helical rod domain composed largely of seven residue
heptad repeats. This domain exists in four segments (1A, 1B,
2A, and 2B) interrupted by three non-helical linkers (L1, L12,
and L2) and a so-called, stutter region (6, 7). The stutter region
is an interruption in the regularity of the heptad repeat sub-
structure, which generates a helix phase reversal near the
middle of the 2B rod domain segment and is considered to be
the result of a deletion of three residues at the junction of two
heptads (8). Although the stutter region is highly conserved
among all IF (7), its molecular functions in KIF assembly
remain unknown.
Mutations in either the KRT5 or KRT14 gene, which encode
the epidermal keratins K5 and K14, respectively, lead to the
epidermolysis bullosa simplex (EBS), the majority of which are
inherited in an autosomal dominant manner and are charac-
terized by intraepidermal blister formation (9). According to
the clinical severity of blister formation, EBS can be subdivided
into three major subtypes (10). The mildest variant is the
Weber-Cockayne type EBS (EBS-WC) with blistering restricted
to the hands and feet, the more moderate variant is the Koeb-
ner type (EBS-K) with generalized blister formation, and the
most severe variant (Dowling-Meara type; EBS-DM) is charac-
terized by severe herpetiform blistering (10).
EBS was the first human keratin disease to be identified
(11–13) that came from the ultrastructural findings demon-
strating the clumping of KIFs in the basal keratinocytes of
patients with EBS-DM (14, 15). Transgenic mice engineered to
express the mutant human K14 exhibited similar phenotypic
and morphological characteristics to EBS-DM, which sug-
gested that keratin mutations disrupt KIF assembly in a dom-
inant negative fashion (16, 17). It showed that if even a small
amount of copolymerizing keratin protein is defective, this is
sufficient to disrupt the whole KIF network. The severity of
EBS has been shown to be dependent upon the structural
implications for each mutation, including its location within
the protein and its effect upon KIF formation (18, 19). The
mutations responsible for EBS-DM lie within the highly con-
served ends of the rod domain, which are critical for proper K5
and K14 filament assembly (11, 20, 21). In contrast, EBS-K
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mutations are also located within the rod domain but are more
centrally located (12, 13) and EBS-WC mutations are mostly
found in the non-helical regions (22- 24).
We have studied an EBS family in which the affected indi-
viduals showed a variable phenotype and have identified two
distinct KRT5 mutations in the proband, the most severely
affected member. He is compound heterozygous for both a
dominant mutation in the helix initiation peptide (HIP) and a
recessive mutation in the stutter region of K5. To confirm
whether the stutter mutation exacerbated the clinical severity
of EBS caused by the dominant mutation on the other allele, we
examined cultured cells transfected with the mutated KRT5
cDNA corresponding to the proband’s mutations. Here we show
evidence that the stutter region plays an important role in the
organization of the KIF network.
EXPERIMENTAL PROCEDURES
EBS Family with Heterogeneous Clinical Presentation—The proband
(Fig. 1, III:4) was a 22-year-old man with blistering over his entire body
from birth and was given a diagnosis of EBS-K. Although the blistering
on the trunk improved with age, he continued to get severe blisters and
erosions on the hands and feet after minor trauma with a worsening of
symptoms during the summer months (Fig. 2). Electron microscopy of
the proband showed that cytolysis occurred within the basal keratino-
cytes consistent with EBS, although apparent clumping of keratin
filaments was not observed (data not shown). His family had several
affected members (Fig. 1). An older brother (III:6) also presented with
blistering over the whole body since birth, with similar clinical findings
to the proband, but died in a traffic accident in childhood. In contrast,
his deceased father (II:6), deceased grandmother (I:2), and his paternal
uncle (II:2) developed few blisters that were restricted to the soles only
after extensive walking. They seldom exhibited blisters with increasing
age; therefore, they were unaware that they had any disease. All of
them were given the diagnosis of EBS-WC, not EBS-K. Thus the mark-
edly heterogeneous clinical presentation in this dominantly inherited
EBS family could not be explained by a single dominant keratin muta-
tion (Fig. 1).
Mutation Analysis—Genomic DNA extracted from peripheral blood
was used as a template for PCR amplification. The KRT5 and KRT14
genes were amplified by the methods previously reported (25, 26).
Specifically, for amplification of the 407-bp DNA fragment comprising
the 339-bp exon 1 of KRT5 (nucleotides 216–555 in the cDNA; Gen-
BankTM accession number NM000424) containing the paternal muta-
tion E170K, the following primers were used; 5-GAGGATATCCAT-
CAGCACTA-3 (forward) and 5-CCTTCTTTCTCTCTTTGGC-3
(reverse). For amplification of the 558-bp DNA fragment comprising the
221-bp of exon 7 of KRT5 (nucleotides 1219–1440 in the cDNA; Gen-
BankTM accession number NM000424) containing the maternal muta-
tion E418K, the following primers were used; 5-GAGAGCCGAGATT-
GACAATG-3 (forward) and 5-TAGAGCAGCCTCGCTTTATC-3
(reverse). Fifty-microliter reactions containing 250 ng of DNA, 200 M
of each dNTP, 450 nM of each primer, 2 units of Amplitaq polymerase,
and 5 l of 10 PCR buffer with 1.5 mM MgCl2 (PerkinElmer Life
Sciences, San Francisco, CA) were initially denatured at 94 °C, followed
by 35 cycles of 1 min at 94 °C, 1 min at 55 °C, and 1 min at 72 °C. DNA
sequencing of all the PCR products was carried out using a Genetic
Analyzer 310A automatic sequencer (PerkinElmer Life Sciences-ABI,
Foster City, CA).
Verification of the Mutations—Because there was no proper restric-
tion enzyme to verify each mutation, we created restriction enzyme
sites recognized by BsrBI. The genomic template was amplified by PCR
under the same conditions with the following primers: for amplification
of the 333-bp DNA fragment containing the E170K mutation and
changing the base from A to G at base 512 in exon 1, forward primer
5-GTGGTGCCGGTAGTGGATT-3 and reverse primer 5-TGTT-
GAGGGTCTTGATCCGC-3 were used. For amplification of the 321-bp
DNA fragment containing the E418K mutation and changing an A to G
at base 1256 in exon 7, forward primer 5-GAAAGAGGGCAAG-
GAAGGGGCCTG-3 and reverse primer 5-TTGAGGGCCAGCTC-
CCCACGCCGC-3 were used. Both mutations (G to A substitutions)
resulted in the loss of the restriction enzyme site for BsrBI.
Plasmid Constructions and Cell Transfection—Using human kerati-
nocyte cDNA as a template, full-length human KRT5 was amplified by
PCR with primer pairs to generate artificial BamHI and HindIII sites
and subjected to nucleotide sequencing. After digestion with these
enzymes, the full-length KRT5 cDNA insert was ligated into pCMV-tag
vectors with a FLAG sequence (pK5F) (Stratagene, La Jolla, CA), which
allows FLAG epitope tagging of the C terminus of the K5 protein. The
point-mutated KRT5 cDNAs corresponding to the E170K and E418K
mutations were generated with the use of the site-directed mutagenesis
system Mutan-Super Express kit (TaKaRa, Japan) and subcloned into
the same vectors (pK5E170KF and pK5E418KF). Madin-Darby canine
kidney (MDCK) cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and 100 units/ml
penicillin and 100 g/ml streptomycin in the presence of 5% CO2. The
day before transfection, the cells were trypsinized, counted, and plated
into a four-welled chamber coverglass at 105 cells per well. Four differ-
ent transfections, including the wild type KRT5 cDNA alone (pK5F), the
combinations with an equimolar ratio of the wild type KRT5 cDNA and
FIG. 1. The EBS family investigated in this study with results
of the genetic mutation in KRT5. WT, wild type; Mut, mutation.
Direct nucleotide sequencing of the proband’s genomic DNA revealed
two heterogeneous missense mutations. One is a heterozygous G to A
transition at nucleotide position 508, which substitutes a glutamic acid
to lysine at residue 170 (E170K) (A). Another is a heterozygous G to A
transition at nucleotide position 1252, which substitutes a glutamic
acid to lysine at residue 418 (E418K) (B). Males (squares), females
(circles), deceased (slashed symbols). The black square represents indi-
viduals who presented with a moderately severe phenotype (EBS-K).
The striped circle or squares denote individuals with a mild clinical
phenotype (EBS-WC). Unaffected individuals are represented by open
symbols. An arrow indicates the proband. The identified mutations
E170K and E418K are indicated under the individual’s symbol (C). To
verify mutations, exon 1 and exon 7 were amplified by PCR with
primers generating new restriction enzyme sites recognized by BsrBI.
E170K and E418K mutations obliterate a BsrBI site. In exon 1, the
mutant alleles remain uncut (333 bp) and wild type alleles are digested
into 315 and 18 bp in length (D), whereas in exon7 the mutant alleles
are 321 bp and wild type alleles are digested into 299 and 22 bp in
length (E). The results confirm heterozygous E170K mutation in the
affected family members (II:2, III:4) and heterozygous E418K mutation
in the proband and the unaffected members (II:7, III:4, III:7).
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the mutated KRT5 cDNA (pK5F/pK5E170KF or pK5F/pK5E418KF),
and the combinations with an equimolar ratio of the two mutated KRT5
cDNA (pK5E170KF/pK5E418KF) were performed using Lipo-
fectAMINE reagent (Invitrogen-BRI, Bethesda, MD) according to the
distributor’s recommendation.
Confocal Laser Analysis—At 24 h after transfection, MDCK cells
were washed with phosphate-buffered saline and fixed in 2% paraform-
aldehyde for 10 min and permeabilized by incubation with 0.5% Tri-
ton-X for 10 min. To detect transfected cells, an anti-FLAG antibody
(Stratagene, La Jolla, CA) was used to recognize the FLAG tag as a
primary antibody (1:100 dilution), and fluorescein-conjugated goat IgG
against mouse IgG (Jackson ImmunoResearch Laboratories) was used
as a secondary antibody. All cells were observed using a confocal laser
scanning microscope (Olympus Fluoview FV300). The cells with keratin
aggregates were counted in three different areas, two from each exper-
imental replicate, and the results obtained from six counts were ex-
pressed as the mean  S.D.
RESULTS
A Patient with EBS Compound Heterozygous for a Dominant
and a Recessive Mutation in KRT5—KRT5 and KRT14, includ-
ing all the exons and exon-intron borders, were amplified using
the proband’s genomic DNA and PCR primers and directly
sequenced. There was no mutation in KRT14, whereas two
novel heterozygous point mutations were found in KRT5. One
mutation was a G to A transversion at base 508, leading to the
exchange of a glutamic acid to lysine at residue 170 (E170K) in
the 1A domain (Fig. 1A). Another mutation was a G to A
transversion at base 1252, leading to the same amino acid
substitution at residue 418 (E418K) in the 2B domain (Fig. 1B).
To verify each mutation, KRT5 was amplified by PCR with
primers generating new restriction enzyme sites recognized by
BsrBI (Fig. 1, D and E). Both mutations (G3 A substitutions)
resulted in the loss of the restriction enzyme site for BsrBI.
These mutations were not found among 100 normal alleles,
suggesting that they are not polymorphisms within the normal
Japanese population. The altered glutamic acid at residue 170
is within the second residue of the HIP, a well conserved motif
among all IF types. Notably, another mutated glutamic acid at
residue 418 in the stutter region of the 2B domain was also
highly conserved among all types of IF (Fig. 3).
Analysis of KRT5 of the proband’s relatives (II:2, II:7, III:5,
III:7) revealed that the E170K mutation was on the paternal
allele and the E418K mutation on the maternal allele. His
affected uncle (II:2), who showed a milder clinical phenotype
(EBS-WC) than the proband’s (EBS-K), had only the E170K
mutation, while his mother (II:7) and his brother (III:7) with
the E418K mutation were clinically normal (Fig. 1C). We there-
fore hypothesized that the E170K mutation caused the
EBS-WC phenotype in the family, and we suggest that the
proband’s clinical phenotype was aggravated by the E418K
mutation consistent with the proband being a compound het-
erozygote for dominant and recessive mutations. Although we
could not perform mutational analysis with DNA from his
deceased older brother (III:6), the similar clinical severity of
EBS suggests that he might also be a compound heterozygote
for dominant (E170K) and recessive (E418K) mutations.
The Mutated K5 Protein Disrupts the KIF Network in
Vitro—We examined whether the clinical heterogeneity of the
EBS family could be demonstrated in a cell culture system.
Three mammalian expression vectors containing the wild type
KRT5 (pK5F), the mutated KRT5 correspondent with the
E170K mutation (pK5E170KF), and the E418K mutation
(pK5E418KF) were constructed. Four distinct gene transfec-
tions using the MDCK cells were performed, including the
pK5F alone, a combination with equimolar ratio of pK5F and
either of pK5E170KF or pK5E418KF, and a combination with
equimolar ratio of the two mutated KRT5 cDNA (pK5E170KF
and pK5E418KF). We chose MDCK cells for the transfection
study, because they do not express endogenous K5 and K14
(27), and previous studies have demonstrated that MDCK cells
transfected with the human KRT9 gene could readily incorpo-
rate K9 into their endogenous KIF network (28).
A monoclonal antibody against the tag sequence, FLAG, was
used to detect the KIF network derived from transfected KRT5.
The cells transfected with pK5F alone showed fine bundles of
keratin filaments extended throughout the cytoplasm without
disturbing the cells’ morphology (Fig. 4, A–C), whereas cells
cotransfected with the wild type and mutated KRT5 gene
(pK5E170KF/pK5F), (pK5E418KF/pK5F), or both mutated
KRT5 (pK5E170KF/pK5E418KF) exhibited small ball-like fil-
ament aggregates indicating a disruption in the keratin net-
work (Fig. 4, D–I).
FIG. 2. Clinical features of the proband. The proband continues to
get occasional blisters and erosion on the soles and palms, particularly
in areas of trauma. Old and new blisters and erosion with crusting are
seen on the soles, heels, and dorsum of toes. The other affected family
members have never presented any similar clinical findings.
FIG. 3. Schematic demonstration of the E170 residue and E418
residue in K5 are highly conserved among IF. The large boxes
encompass the central -helical rod domain, separated into four seg-
ments (1A, 1B, 2A, 2B) by virtue of short non-helical linker segments
(L1, L1–2, and L2). Helix initiation peptide (HIP) and helix termination
peptide (HTP) denote the highly conserved end domains of the rod
domain. Shown are amino acid sequences of the HIP and the stutter
region near the middle of the 2B rod domain segment along with: a
selected group of other type II IF keratins, type III IF vimentin, type IV
IF neurofilament subunit M (NF-M), type V IF lamin. V, variable
region; H, homology region; L, linker; S, stutter; hu, human. The se-
quences were obtained from the GenBankTM. GenBankTM accession
numbers are as follows (hu K1, AF237621; hu K2e, AF019084; hu K3,
X05418 and X05421; hu K4, X61028; hu K5, NM000424; hu K6a,
L42583; hu vimentin, BC000163; hu NF-M, Y00067; hu-lamin,
M13451).
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The Stutter Mutation E418K Exacerbated the KIF Network
Disturbance—The percentage of the cells with keratin clump-
ing in each transfection assay was as follows, pK5F (1.5  1.8),
pK5F/pK5E418KF (4.4  1.7), pK5F/pK5E170KF (12.7  4.3),
and pK5E170KF/pK5E418KF (30.0  3.1) (Fig. 5). Statistical
analysis showed that significantly more clumped cells were
observed in cells cotransfected with pK5E170KF/pK5E418KF
than those with pK5F/pK5E170KF (p  0.05). These results
suggested that the compound heterozygous mutations (E170K
and E418K) within the keratin genes resulted in a more severe
keratin network disturbance than the heterozygote for domi-
nant mutation (E170K) alone in vitro. This is concordant with
the markedly variable severity of EBS phenotype in this
family.
DISCUSSION
We have presented the first case of a compound heterozygote
with both dominant and recessive mutations, and have dem-
onstrated that the recessive stutter region mutation (E418K) in
KRT5 exacerbated the disruption in the KIF network caused by
the dominant mutation (E170K). Although most cases of EBS
are autosomal dominant and are caused by missense mutations
(9), whether they are fully or partially dominant is still not
clear. For example, a partial dominant KRT14 mutation was
found in an EBS family with consanguineous marriage, in
which homozygotes had a more severe clinical phenotype than
heterozygotes (29).
Usually, compound heterozygous genotypes involve different
recessive alleles at the same locus; nevertheless, in some dis-
eases compound heterozygotes with one dominant allele and
one recessive allele are known (30). In these cases, although the
heterozygous individuals with a recessive allele are phenotyp-
ically normal, heterozygotes for the dominant allele develop the
disease, and compound heterozygotes usually manifest more
severe symptoms than heterozygotes due to the dominant allele
(30). For instance, we recently reported such cases of dystro-
phic epidermolysis bullosa in which type VII collagen was the
defective gene (31). Heterozygotes with a dominant glycine
substitution mutation in COL7A1 presented with only toe nail
dystrophy without skin fragility, whereas compound heterozy-
gotes for this dominant and recessive mutation led to dystro-
phic epidermolysis bullosa with marked skin fragility (32–33).
In this study, the mother and brother who were heterozygous
for the E418K mutation were clinically normal, however, it was
difficult to demonstrate such a subclinical abnormality in vivo.
We examined how the E418K mutation would influence KIF
formation in vitro using a transfection assay, for which several
studies have been done to examine how EBS mutations perturb
the KIF assembly (27, 34, 35). In cultured EBS keratinocytes,
keratin aggregates were observed in the majority of EBS-DM
keratinocytes but in only a few of the EBS-K cultures (19). Cells
transfected with a mutated keratin gene corresponding to each
type of EBS showed similar results (19), suggesting that the
transfection assay correlated well with the clinical severity of
EBS and to the degree to which a particular mutation perturbed
filament assembly. In our study, the keratin aggregate formation
was observed in significantly more cells when cotransfected with
E170K and E418K mutations, which was concordant with the
clinical findings. This indicates that the E418K mutation exac-
erbates KIF disruption, similar to the proband phenotype.
The locations of these EBS mutations in the keratin gene
FIG. 4. The mutated K5 protein dis-
rupts the KIFs network in vitro.
MDCK cells were transfected with plas-
mid pK5F (A–C) or cotransfected with
pK5E170KF/pK5F (D–F) or pK5E170KF/
pK5E418KF (G–I). To visualize the trans-
fected gene product, cells were stained
with a rat monoclonal antibody recogniz-
ing the C-terminal sequence of FLAG. An-
tibody staining was followed by fluores-
cein isothiocyanate-conjugated goat anti-
rat IgG. Cells transfected with pK5F
alone had a normal keratin filament net-
work (A–C), whereas significantly more
cells transfected with pK5E170KF/pK5F
(D–F), pK5E170KF/pK5E418KF (G–I),
and a few of the cells transfected with
pK5E418KF/pK5F (data not shown) ex-
hibited small ball-like clump formation
(arrows).
FIG. 5. The keratin clumps were most frequently observed in
cells cotransfected with two mutated KRT5 (pK5E170KF/
pK5E418KF). The percentage of cells showing keratin aggregate for-
mation among transfected cells was compared. There were significantly
more clumps observed in the pK5E170KF/pK5E418KF-transfected cells
than in those transfected with pK5E170KF/pK5F. Each value shown
represents the mean  S.D. of six individual samples. Statistical sig-
nificance of the differences between groups was assessed using the
Student’s t test (*, p  0.05).
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structure are known to correlate with the disease severity. We
know that the ends of the rod domain, HIP and helix termina-
tion peptide (HTP), where most EBS-DM mutations are situ-
ated, are important areas in which K5 and K14 assemble into
filaments (11, 20, 21). Recent research has suggested a role for
each region of keratin proteins in heterodimer formation, helix
stabilization, and filament assembly (36–38), nevertheless,
much about IF structure and function remains unknown.
Particularly, the functions of the IF stutter region have yet to
be fully elucidated. The fact that the stutter region is highly
conserved among all IFs (7) indicates its importance in IF
structure and function. Two computer-based molecular models
of the stutter region have been proposed. Steinert and North et
al. (39, 40) concluded that the stutter was limited to a very short
distance and, therefore, did not cause a significant interruption
or kink in the coiled-coil  helix structure. Conversely, Brown et
al. (41) proposed that the unwound coiled-coil model, in which the
stutter is located, may contribute to filament flexibility, suggest-
ing that it has a profound effect on the structure and can modify
both the assembly and interactions of these protein.
The relatively important contribution of the stutter region in
IF formation was shown by Hermann et al. (36, 42) using the
“stutterless” recombinant type III IF, vimentin. This stutter-
less vimentin assembled into seemingly normal “uni-length”
fibrils, whose formation was the first important step in the as-
sembly, but elongation of these short IFs into longer filaments
was slowed down considerably (36, 42). It suggested that the
stutter region might play specific roles in the elongation of IFs.
Although glutamic acid at residue 418 in the stutter region
has been extremely highly conserved among different IFs (Fig.
3), only a few cells cotransfected with pK5E418K/pK5F exhib-
ited keratin clumping in this study. One reason for this is that,
because both glutamic acid and lysine are polar amino acids,
this substitution doesn’t influence the irregularity of the hep-
tad repeats in the stutter, resulting in a limited influence on
KIF formation. Another possibility is that the stutter region
may contribute to the elongation of KIFs rather than the coiled-
coil heterodimer formation as Hermann suggested (42). Muta-
tions affecting the early stage of KIF assembly would be expected
to have the most severe effects on the KIF network for assembly
causing EBS-DM, whereas mutations in areas involved in the
higher order KIF assembly processes might have more subtle
effects similar to EBS-WC. However, the fact the E418K muta-
tion can exacerbate KIF disturbance when combined with a path-
ogenic mutation on the other allele suggests the stutter region
plays some role in the KIF network organization.
In conclusion, we have shown that a compound heterozygote
for a dominant and a recessive KRT5 mutation can result in a
more severe disturbance in KIF assembly than a heterozygote
for a dominant mutation in vitro. We confirmed the fact that
the recessive mutation found in the stutter region of the K5
molecule exacerbated this KIF disturbance. These results and
transfection assay data emphasize the sensitivity and impor-
tance of the stutter region in the structural alterations and
organization of the KIF network.
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